Fiscal Year Ended

May 2, 2026

May 3, 2025

April 27, 2024

(52 Weeks)

(53 Weeks)

(52 Weeks)

Net income (loss) attributable to Methode (in millions)

$

(35.7

)

$

(62.6

)

$

(123.3

)

Basic weighted average shares outstanding

35,521,615

35,330,586

35,470,471

Dilutive effect of common stock equivalents

—

—

—

Diluted weighted average shares outstanding

35,521,615

35,330,586

35,470,471

Income (loss) per share attributable to Methode:

Basic

$

(1.01

)

$

(1.77

)

$

(3.48

)

Diluted

$

(1.01

)

$

(1.77

)

$

(3.48

)

Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding

410,350

1,156,752

1,429,229